NCT07216495View on ClinicalTrials.gov

Pilot Study of an Aerobic Exercise Intervention During Immune Checkpoint Inhibitor Therapy in Early-stage Triple Negative Breast Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 6, 2026

Primary Completion Date

October 30, 2028

Study Completion Date

October 30, 2030

Conditions
Aerobic ExerciseEarly Stage Triple Negative Breast Cancer
Interventions
OTHER

Exercise

Cardiorespiratory training via treadmill walking for 30 minutes; participants will be supervised by a trained exercise physiologist.

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER